Remodeling of plasma lipoproteins in patients with rheumatoid arthritis: Interleukin-6 receptor-alpha inhibition with tocilizumab

2015 ◽  
Vol 10 (2) ◽  
pp. 183-194 ◽  
Author(s):  
Janet S. Lee ◽  
M. John Chapman ◽  
Paolo Piraino ◽  
Jens Lamerz ◽  
Thomas Schindler ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Interleukin 6 ◽  
Plasma Lipoproteins ◽  
Receptor Alpha ◽  
Interleukin 6 Receptor

The effect of tocilizumab - an interleukin-6 receptor antagonist - on lipid levels in rheumatoid arthritis

2017 ◽  
Author(s):  
Ifigenia Kostoglou-Athanassiou ◽  
Lambros Athanassiou ◽  
Aikaterini Tzanavari ◽  
Charoula Katsavouni ◽  
Markos Kostopoulos ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Receptor Antagonist ◽  
Interleukin 6 ◽  
Lipid Levels ◽  
Interleukin 6 Receptor

scholarly journals CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis

2015 ◽  
Vol 17 (1) ◽  
Author(s):  
Zafar Mahmood ◽  
Khalid Muhammad ◽  
Marc Schmalzing ◽  
Petra Roll ◽  
Thomas Dörner ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
B Cells ◽  
Interleukin 6 ◽  
Memory B Cells ◽  
Interleukin 6 Receptor

scholarly journals Interleukin 6 receptor alpha expression in PMNs isolated from prematurely born neonates: decreased expression is associated with differential mTOR signaling

2019 ◽  
Vol 86 (1) ◽  
pp. 55-62
Author(s):  
Robert A. Campbell ◽  
Mark J. Cody ◽  
Bhanu K. Manne ◽  
Guy A. Zimmerman ◽  
Christian C. Yost
Keyword(s):  
Interleukin 6 ◽  
Mtor Signaling ◽  
Receptor Alpha ◽  
Interleukin 6 Receptor
Sign in / Sign up

Export Citation Format

Share Document